Tumor Infiltrating Lymphocytes

Explore clinical trials studying Tumor Infiltrating Lymphocytes. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Tumor Infiltrating Lymphocytes trial results

Recruiting

A Study of GC203 TIL in PDCA (RJ)

NCT06828328

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

NCT05087745

Conditions: Advanced Solid Tumor, Effects of Immunotherapy, Treatment Side Effects, +1 more
Locations: Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Study of TIL in Advanced Solid Tumors (DFGD)

NCT06488950

Conditions: Advanced Solid Tumor, Effects of Immunotherapy, Treatment Side Effects, +1 more
Locations: Third Affiliated Hospital of Naval Medical University Shanghai, China

View Trial Details

Recruiting

Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

NCT07035002

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +11 more
Locations: Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, None Selected, China

View Trial Details

Not yet recruiting

Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer

NCT05152797

Conditions: Tumor Infiltrating Lymphocytes
Locations: Not specified

View Trial Details

Completed

A Study of GC101 TIL in Advanced Melanoma (BZ)

NCT06120712

Conditions: Adverse Drug Event, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +15 more
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details

Completed

A Phase I Study of GC101 TIL in Advanced Solid Tumors

NCT05417750

Conditions: Advanced Solid Tumor, Adverse Drug Event, Chemically-Induced Disorders, +5 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Tumor Infiltrating Lymphocytes

Tumor Infiltrating Lymphocytes trial results

A Study of GC203 TIL in PDCA (RJ)

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

A Study of TIL in Advanced Solid Tumors (DFGD)

Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer

A Study of GC101 TIL in Advanced Melanoma (BZ)

A Phase I Study of GC101 TIL in Advanced Solid Tumors

Related conditions